Cerity Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.7M	Buy	6,086 +635	+12%	+$183K	﹤0.01%	1573
2025 Q4	$1.65M	Buy	5,451 +570	+12%	+$178K	﹤0.01%	1453
2025 Q3	$1.37M	Sell	4,881 -499	-9%	-$136K	﹤0.01%	1456
2025 Q2	$1.3M	Sell	5,380 -1,492	-22%	-$353K	﹤0.01%	1411
2025 Q1	$1.67M	Sell	6,872 -607	-8%	-$183K	﹤0.01%	1203
2024 Q4	$2.5M	Sell	7,479 -314	-4%	-$107K	0.01%	1007
2024 Q3	$2.61M	Buy	7,793 +1,767	+29%	+$561K	0.01%	969
2024 Q2	$1.65M	Sell	6,026 -1,723	-22%	-$501K	﹤0.01%	998
2024 Q1	$2.68M	Buy	7,749 +6,858	+770%	+$2.26M	0.01%	862
2023 Q4	$288K	Buy	+891	New	+$279K	﹤0.01%	1543
2023 Q2	–	Sell	-953	Closed	-$877K	–	1675
2023 Q1	$877K	Buy	953 +115	+14%	+$53.8K	﹤0.01%	1038
2022 Q4	$352K	Buy	838 +336	+67%	+$136K	﹤0.01%	1090
2022 Q3	$209K	Buy	502 +65	+15%	+$32.4K	﹤0.01%	1041
2022 Q2	$216K	Buy	+437	New	+$228K	﹤0.01%	1050
2022 Q1	–	Sell	-371	Closed	-$282K	–	951
2021 Q4	$282K	Buy	+371	New	+$278K	﹤0.01%	798
2019 Q2	–	Sell	-707	Closed	-$216K	–	494
2019 Q1	$216K	Buy	+707	New	+$191K	0.01%	485